| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2014 | Epidemiology and natural history of hepatitis C virus infection. | Lee, MH; Yang, HI; Yuan, Y; L’Italien, G; Chen, CJ | World journal of gastroenterology : WJG 20(28), 9270-80 | | | |
| 2015 | Epidemiology of virus infection and human cancer | Liu, J; Yang, HI; Lee, MH; Hsu, WL; Chen, HC; Chen, CJ | Infection and Cancer: Bi-Directorial Interactions (Switzerland : Springer International Publishing Switzerland) | | | |
| 2014 | Epidemiology of virus infection and human cancer | Chen, CJ; Hsu, WL; Yang, HI; Lee, MH; Chen, HC; Chien, YC; You, SL | Viruses and Human Cancer (Berlin Heidelberg : Springer-Verlag Berlin Heidelberg) | | | |
| 2014 | Epidemiology of virus infection and human cancer | Chen, CJ; Hsu, WL; Yang, HI; Lee, MH; Chen, HC; Chien, YC; You, SL | RECENT RESULTS IN CANCER RESEARCH 193, 11-32 | | | |
| 2014 | Estimating the Incidence and Prevalence of Chronic Hepatitis C Infection in Taiwan Using Back Projection. | McEwan, P; Ward, T; Chen, CJ; Lee, MH; Yang, HI; Kim, R; L'Italien, G; Yuan, Y | Value in health regional issues 3, 5-11 | | | |
| 2015 | External validation of Fatty liver index for identifying ultrasonographic Fatty liver in a large-scale cross-sectional study in taiwan. | Yang, BL; Wu, WC; Fang, KC; Wang, YC; Huo, TI; Huang, YH; Yang, HI; Su, CW; Lin, HC; Lee, FY; Wu, JC; Lee, SD | PloS one 10(3), e0120443 | | | |
| 2012 | Fifteen-year population attributable fractions and causal pies of risk factprs for newly developed hepatocellular carcinoma in 11,801 male residents in Taiwan | Liao, SF; Yang, HI; Lee, MH; Chen, CJ; Lee, WC | PLoS One 7, e34779 | | | |
| 2012 | Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study | Wu, HC; Wang, Q; Yang, HI; Tsai, WY; Chen, CJ; Santella, RM | Carcinogenesis 33(7), 1340-1345 | | | |
| 2009 | Hepatitis B virus DNA levels and outcomes in chronic hepatitis B | Chen, CJ; Yang, HI; Ioleje, UH | Hepatology 49,S72-S84 | | | |
| 2017 | Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study | Lai, TS; Lee, MH; Yang, HI; You, SL; Lu, SN; Wang, LY; Yuan, Y; L'Italien, G; Chien, KL; Chen, CJ | Hepatology (Baltimore, Md.) 66(3), 784-793 | | | |
| 2010 | Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: Long-term predictors from a community-based cohort study | Lee, MH; Yang, HI; Lu, SN; Jen, CL; Yeh, SH; Liu, CJ; Chen, PJ; You, SL; Wang, LY; Chen, WJ; Chen, CJ | J Clin Oncol 28:4587-4593 | | | |
| 2015 | Hepatocellular carcinoma risk scores: ready to use in 2015? | Chen, CJ; Lee, MH; Liu, J; Yang, HI | Hepat Oncol 2, 1-4 | | | |
| 2017 | High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease | Lai, TS; Lee, MH; Yang, HI; You, SL; Lu, SN; Wang, LY; Yuan, Y; L'Italien, G; Chien, KL; Chen, CJ | Kidney international 92(3), 703-709 | | | |
| 2013 | Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients | Cheng, HR; Liu, CJ; Tseng, TC; Su, TH; Yang, HI; Chen, CJ; Kao, JH | PLoS One 8:e53008 | | | |
| 2018 | Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: A genome-wide association study. | Lee, MH; Huang, YH; Chen, HY ; Khor, SS; Chang, YH; Lin, YJ; Jen, CL; Lu, SN; Yang, HI; Nishida, N; Sugiyama, M; Mizokami, M; Yuan, Y; L'Italien, G; Tokunaga, K; Chen, CJ | Hepatology (Baltimore, Md.) 67(2), 651-661 | | | |
| 2010 | Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based long-term follow-up study | Liu, J; Yang, HI; Lee, MH; Lu, SN; Jen, CL; Wang, LY; You, SL; Iloeje, UH; Chen, CJ | Gastroenterology 139(2), 474-482 | | | |
| 2012 | Incidence and determinants of spontaneous seroclearance of HB e antigen and DNA in patients with chronic hepatitis B | Yang, HI; Hung, HL; Lee, MH; Liu, J; Jen, CL; Su, J; Wang, LY; Lu, SN; You, SL; Iloeje, UH; Chen, CJ; REVEAL-HBV Study Group | Clin Gastroenterol Hepatol 10(5), 527-534 | | | |
| 2017 | Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply. | Lin, D; Yang, HI; Hoang, J; Nguyen, MH | Alimentary pharmacology & therapeutics 45(1), 186-187 | | | |
| 2017 | Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? Authors' reply. | Lin, D; Yang, HI; Hoang, J; Nguyen, MH | Alimentary pharmacology & therapeutics 45(1), 182-183 | | | |
| 2011 | Lifetime risk and gender difference of hepatocellular carcinoma among patients affected with chronic hepatitis B and C | Huang, YT; Jen, CL; Yang, HI; Lee, MH; Su, J; Lu, SN; Iloeje, UH; Chen, CJ; REVEAL-HBV/HCV Study Group | Journal of Clinical Oncology 29(27), 3643-3650 | | | |
